ABSTRACT & AWARDS

CALL FOR ABSTRACTS

VS 2027 Seoul invites you to submit your abstract(s) for the scientific program.
This meeting presents an excellent opportunity to share scientific knowledge and build professional networks on a global scale.

The online abstract submission for FREE PAPERS and INVITED TALKS will be available in due course.

Important Dates

Abstract Submission Deadline by November 30, 2026
Notification of Acceptance from January 18, 2027
Presenting Author’s Registration Deadline* by March 9, 2027
  • Presenting authors must complete registration by the above deadline.
    Abstracts will not be included in the final program or proceedings if registration and payment are not completed by this date.

Presentation Types

  • Oral Presentation

    • You can apply for the oral presentation where you will have an opportunity to present your work directly to the audience at the conference.

  • Poster Presentation

    • Interesting and inspiring studies related to vestibular schwannoma and other CPA tumors will be displayed in the poster session. Also, abstracts of exceptional qualities can be requested to be presented orally.

Abstract Topics

Abstract Topics
01 Epidemiology and Natural History
02 Basic and Translational Research (Preclinical)
03 NF2 / Schwannomatosis: Molecular Biology and Clinical Management
04 Anatomy, Imaging and Radiomics
05 Observation and Conservative Management
06 Microsurgery: Techniques, Outcomes and Complications
07 Radiosurgery and Radiation Therapy
08 Facial Nerve: Preservation, Monitoring and Rehabilitation
09 Hearing Preservation, Cochlear Implantation and Auditory Rehabilitation
10 Quality of Life, Patient-Reported Outcomes
11 Clinical Trials and Emerging Pharmacotherapy
12 Artificial Intelligence and Digital Health
13 Other CPA and Lateral Skull Base Tumors
14 Video Report
15 Others

Abstract Submission Guidelines

Abstract Submission Guidelines
Submission
  • Abstract can only be submitted online through the official website.
    Abstract submission by email or fax will not be accepted.
  • Submission of an abstract implies that it has been approved by all listed authors.
Language
  • English
Title
  • The title may not exceed 30 words.
  • Refrain from using abbreviations in the title.
Author
  • Given names and surnames for all co-authors must be provided.
  • Do not include degrees or titles.
Institution
  • List all authors' affiliations by department, institution, and country.
Contents
  • Contents may be organized as the author sees fit, though they should include the purpose of the study, the methods used, a summary of the results and the conclusion reached. Please include concrete results, and avoid “research is in progress” or “results will be discussed.”
  • The contents may not exceed 300 words.
  • All abbreviations must be defined in first use. Only standard abbreviations may be used without definition.
    Data must be given in units widely used in literature (the international metric system is preferred).
  • Abstracts will be reproduced exactly as submitted and will not be edited in any way.
    The authors are responsible for all spelling, grammatical or scientific errors.
  • Modifications may be made at any time until the abstract submission deadline.
Keywords
  • Three keywords must be entered.
Originality
  • Abstracts must be original and must not have been published at the time of abstract submission.
Conflicts of Interest
  • To avoid any commercial bias, all authors must disclose conflicts of interest in the presentation.
Copyright
  • The content belongs to the author(s). By submitting the abstract, the author(s) also grant VS 2027 Seoul free of charge the non-exclusive right to edit, publish, display, distribute, store the abstract and make all types of derivative works in all forms, formats, and media, now known or hereinafter developed.
  • The authors retain the right, after presentation, to subsequently include the work in articles, books, or derivative works that he/she authors or edits, provided said use does not imply the endorsement of the VS 2027 Seoul.
  • Abstract withdrawal is only permitted if notified in writing to scientific@vs2027.org and confirmed by the secretariat within 14 days of notification of acceptance.
  • The Scientific Committee reserves the right to withdraw any abstracts that do not meet the scientific standards of VS 2027 Seoul at any point before or after acceptance.

Notification of Acceptance

The Scientific Committee will review the abstracts, and the notification of acceptance will be sent from January 18, 2027 along with presentation instructions. If your abstract is accepted, please be sure that the presenting author registers for VS 2027 Seoul by the presenting author’s registration deadline. If the presenting author does not register and pay in full by this date, the abstract will not be included in the program.

Copyright Protection

All materials presented and/or published at the 10th Quadrennial International Conference on Vestibular Schwannoma and Other CPA Tumors are valuable research assets. The Organizing Committee of VS 2027 Seoul strictly prohibits duplication, reproduction, storage and/or transmission for any commercial purpose.

Unauthorized reproduction, distribution, transmission, and commercial use of any presented and/or published materials of VS 2027 Seoul is a serious offense of copyright infringement, and upon violation of such conducts, the Organizing Committee may take civil and criminal legal actions against them.

TOP